Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20171015036782N11Phase 3Completed
Phase 3, randomised, double-blind trial in anxiety disorder and acute pain comparing Placebo, Midazolam and Zolpidem (3 arms). Primary endpoint: Pain intensity. Started Jun 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20171015036782N11.